Company

Revance Therapeutics, Inc.

Revance develops therapeutic and aesthetic products for appearance and skin health.

About

Founded in 1999, Revance Therapeutics is based in Nashville, US, and develops therapeutic and aesthetic products. Its offerings include DAXXIFY®, the Teoxane RHA® Collection, SkinPen® Precision and BIOJUVE®. The company reported revenue of USD 234.04 mn and EBITDA of USD -307.13 mn in 2023.

6Funding rounds

11Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in